Ameritas Investment Partners’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.3K | Buy |
4,311
+1,216
| +39% | +$11.7K | ﹤0.01% | 2309 |
|
|
2025
Q1 | $19.4K | Hold |
3,095
| – | – | ﹤0.01% | 2571 |
|
|
2024
Q4 | $25.1K | Hold |
3,095
| – | – | ﹤0.01% | 2536 |
|
|
2024
Q3 | $56K | Hold |
3,095
| – | – | ﹤0.01% | 2123 |
|
|
2024
Q2 | $31.9K | Hold |
3,095
| – | – | ﹤0.01% | 2386 |
|
|
2024
Q1 | $32.9K | Hold |
3,095
| – | – | ﹤0.01% | 2354 |
|
|
2023
Q4 | $28.3K | Hold |
3,095
| – | – | ﹤0.01% | 2427 |
|
|
2023
Q3 | $32.1K | Buy |
3,095
+1,507
| +95% | +$15.6K | ﹤0.01% | 2323 |
|
|
2023
Q2 | $22.7K | Hold |
1,588
| – | – | ﹤0.01% | 2503 |
|
|
2023
Q1 | $11.3K | Hold |
1,588
| – | – | ﹤0.01% | 2692 |
|
|
2022
Q4 | $13.9K | Hold |
1,588
| – | – | ﹤0.01% | 2704 |
|
|
2022
Q3 | $17K | Hold |
1,588
| – | – | ﹤0.01% | 2601 |
|
|
2022
Q2 | $13K | Hold |
1,588
| – | – | ﹤0.01% | 2754 |
|
|
2022
Q1 | $22K | Hold |
1,588
| – | – | ﹤0.01% | 2522 |
|
|
2021
Q4 | $31K | Hold |
1,588
| – | – | ﹤0.01% | 2423 |
|
|
2021
Q3 | $51K | Hold |
1,588
| – | – | ﹤0.01% | 2148 |
|
|
2021
Q2 | $54K | Buy |
1,588
+663
| +72% | +$22.5K | ﹤0.01% | 2128 |
|
|
2021
Q1 | $35K | Hold |
925
| – | – | ﹤0.01% | 2289 |
|
|
2020
Q4 | $31K | Hold |
925
| – | – | ﹤0.01% | 2259 |
|
|
2020
Q3 | $34K | Hold |
925
| – | – | ﹤0.01% | 2080 |
|
|
2020
Q2 | $30K | Hold |
925
| – | – | ﹤0.01% | 2136 |
|
|
2020
Q1 | $24K | Hold |
925
| – | – | ﹤0.01% | 2076 |
|
|
2019
Q4 | $29K | Buy |
+925
| New | +$29K | ﹤0.01% | 2225 |
|